Structure-Based Lead Optimization of Enterovirus D68 2A Protease Inhibitors

Bin Tan1, Chang Liu2, Kan Li1

  • 1Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United States.

PubMed
Summary

New antiviral compounds targeting the Enterovirus D68 (EV-D68) 2A protease were developed. Structure-based optimization of telaprevir led to potent inhibitors, offering hope for EV-D68 treatment.

Related Concept Videos